Results 221 to 230 of about 48,035 (283)

Clinical outcomes and early- prognostic biomarkers of primary biliary cholangitis with ductopenia. [PDF]

open access: yesFront Immunol
Wang W   +8 more
europepmc   +1 more source

Machine Learning Approach Enables Highly Accurate Identification of At‐Risk Metabolic Dysfunction‐Associated Steatohepatitis

open access: yesHepatology Research, Volume 56, Issue 5, Page 753-761, May 2026.
ABSTRACT Aim At‐risk metabolic dysfunction‐associated steatohepatitis (MASH), characterized by significant activity and fibrosis, increases the risk of liver complications. Liver stiffness measurement (LSM), commonly used to detect significant fibrosis, has limitations in terms of accessibility and performance in certain populations.
Masaya Sato   +15 more
wiley   +1 more source

Altered sphingolipid profile in primary biliary cholangitis: associations with fibrosis and inflammation. [PDF]

open access: yesSci Rep
Rogalska M   +9 more
europepmc   +1 more source

Phage Therapy: Targeting the Gut Microbiota for the Treatment of Acute Pancreatitis

open access: yesJournal of Gastroenterology and Hepatology, Volume 41, Issue 5, Page 1446-1458, May 2026.
ABSTRACT Acute pancreatitis (AP) is a common clinical inflammatory condition whose severity is closely associated with both local pancreatic injury and systemic complications. Research indicates that gut microbiota dysbiosis and subsequent bacterial translocation can exacerbate disease progression via the gut–pancreas axis, representing a critical ...
Jiawei Chen   +4 more
wiley   +1 more source

Impact of Disease‐Specific Treatment and Non‐Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC

open access: yesLiver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background Portal vein thrombosis (PVT) is a common sequela of cirrhosis. Despite regression of fibrosis/cirrhosis observed among some patients after disease‐specific treatment, few studies have considered the role of treatment and response on risk of PVT among patients with cirrhosis across different liver disease states.
Humberto C. Gonzalez   +10 more
wiley   +1 more source

Proteomics identifies complement protein signatures in patients with primary biliary cholangitis. [PDF]

open access: yesEur J Med Res
Ma X   +8 more
europepmc   +1 more source

Late mortality and morbidity after liver transplantation. [PDF]

open access: yes, 1987
Esquivel, CO   +8 more
core  

Diagnostic and Prognostic Values of Bile Biomarkers for Malignant Biliary Stenosis

open access: yesLiver International, Volume 46, Issue 5, May 2026.
ABSTRACT Introduction Differentiating between malignant and benign biliary strictures remains a clinical challenge because current diagnostic tools have limited sensitivity. The detection of tumour‐related biomarkers directly in bile, which is in close contact with the lesion, may enhance diagnostic accuracy.
E. Gigante   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy